Search results for: 'c2 frost comput'
- Related search terms
- frost amp sullivan's accountsignout helpcontactsitemap healthcare home research events blog forum peerconnect tags switch community
- frost amp sullivan believes that global nsps are investing between 50 billion and (6(6 billion) annually on their mobile and wireles
- computational AND chemistry
- Frost & Sullivan: Global and Chinese Pharmaceutical Market Research Report
- frost sullivan global ad chinese pharmaceutical market research report
-
11 Nov 2025  |  Global  |  Technology Research
Frost Radar™: Digital Biomanufacturing of Viral Vectors, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Viral vectors are a critical part of gene therapies and genetic medicines, which are the cornerstone of precision medicines to cure rare diseases, cancers, and genetic disorders. Traditional bioprocessing, however, is tedious, less flexible, batch-based, and heavily manual; as a result, manufacturing processes involve high costs, scalability issues...
$4,950.00 -
12 May 2026  |  Global  |  Frost Radar
Frost Radar™: Managed Security Services in EMEA, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The EMEA managed security services (MSS) market is undergoing rapid transformation as organizations face escalating cyber threats, growing operational complexity, persistent talent shortages, and an increasingly demanding regulatory landscape. This Frost Radar™ study assesses the competitive positioning of leading MSS providers in EMEA in 2026, ben...
$4,950.00 -
18 May 2026  |  Global  |  Frost Radar
Frost Radar™: Smart Delivery Formulations for Biologics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...
$4,950.00 -
11 Sep 2026  |  Global  |  Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generation of evidence to support the drug’s value proposi...
$4,950.00 -
16 Nov 2021  |  Global  |  Frost Radar
Frost Radar™: Americas Managed & Professional Security Services Market, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The Frost Radar™ is Frost & Sullivan’s proprietary benchmarking analysis. The Frost Radar™ evaluates companies’ performance along the axes of innovation and growth. The analysis benchmarks competitors across multiple dimensions, including revenue growth rate, product portfolio, strategy, and innovation capabilities. The document includes competitiv...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Oct 2026  |  Asia Pacific  |  Frost Radar
Frost Radar™: Customer Experience Management Services in Australia, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ examines the Australian customer experience (CX) management services landscape, which is a subset of the broader business process outsourcing/management industry. In a CX management arrangement, a company contracts an outside supplier to run customer service work instead of doing it in-house. The work ranges from handling simple c...
$4,950.00 -
15 Apr 2026  |  Europe  |  Frost Radar
Frost Radar™: Customer Experience Management Services in Europe, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ examines the European customer experience (CX) management services landscape, which is a subset of the broader business process outsourcing/management industry. Usually, CX management is a business arrangement in which a company contracts an outside supplier to perform a service rather than accomplishing it in-house. Services can ...
$4,950.00 -
12 May 2026  |  Global  |  Frost Radar
Frost Radar™: Intelligent Virtual Agents for Customer Experience, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The customer experience (CX) automation market has reached an inflection point. Legacy interactive voice response systems and rule-based chatbots, designed to route and deflect rather than understand and resolve, are being displaced by a new generation of intelligent virtual agents (IVAs) capable of comprehending intent, maintaining context across ...
$4,950.00 -
26 Aug 2026  |  North America  |  Frost Radar
Frost Radar™: Customer Experience Platforms in North America, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
A customer experience platform (CXP) brings order to the complexity of modern customer interactions, covering multiple channels and touchpoints to deliver a journey that is seamless, consistent, and personalized. Providers featured in this Frost Radar™ analysis offer a full-fledged native CXP that includes contact center software, AI, omnichannel e...
$4,950.00 -
11 Dec 2023  |  Asia Pacific  |  Frost Radar
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...
$4,950.00
Special Price $3,712.50 save 25 %